Xin Ge

1.6k total citations · 1 hit paper
26 papers, 985 citations indexed

About

Xin Ge is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Xin Ge has authored 26 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Oncology. Recurrent topics in Xin Ge's work include Ubiquitin and proteasome pathways (9 papers), interferon and immune responses (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Xin Ge is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), interferon and immune responses (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Xin Ge collaborates with scholars based in China and United States. Xin Ge's co-authors include Weijuan Pan, Jiali Jin, Xinbo Wang, Ping Wang, Xiao Tan, Linlin Zhao, Hongshang Chu, Hongling Tian, Xinbo Wang and Lu Deng and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Xin Ge

26 papers receiving 977 citations

Hit Papers

Stem Cell Factor SOX2 Confers Ferroptosis Resistance in L... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Ge China 16 739 245 180 176 162 26 985
Megan Keniry United States 17 1.2k 1.7× 233 1.0× 106 0.6× 129 0.7× 318 2.0× 38 1.5k
Xicheng Mao United States 12 660 0.9× 299 1.2× 238 1.3× 56 0.3× 197 1.2× 19 979
David Klinkebiel United States 18 691 0.9× 163 0.7× 320 1.8× 59 0.3× 258 1.6× 35 1.1k
Amy Goodale United States 9 664 0.9× 109 0.4× 80 0.4× 103 0.6× 159 1.0× 16 861
Shimeng Zhang China 17 456 0.6× 180 0.7× 162 0.9× 52 0.3× 151 0.9× 36 765
Yunping Lu China 18 762 1.0× 324 1.3× 125 0.7× 75 0.4× 287 1.8× 77 1.1k
Kay Hänggi United States 10 498 0.7× 128 0.5× 355 2.0× 91 0.5× 265 1.6× 16 839
Andreas Kloetgen United States 18 1.2k 1.6× 314 1.3× 207 1.1× 52 0.3× 164 1.0× 30 1.5k
Xiangming Ding China 19 1.2k 1.6× 636 2.6× 93 0.5× 92 0.5× 181 1.1× 35 1.5k
Apollina Goel United States 18 639 0.9× 110 0.4× 138 0.8× 102 0.6× 258 1.6× 23 1.1k

Countries citing papers authored by Xin Ge

Since Specialization
Citations

This map shows the geographic impact of Xin Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Ge more than expected).

Fields of papers citing papers by Xin Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Ge. The network helps show where Xin Ge may publish in the future.

Co-authorship network of co-authors of Xin Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Ge. A scholar is included among the top collaborators of Xin Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Ge. Xin Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Yu, et al.. (2024). USP21 stabilizes immune checkpoint of CD276 and serves as an immunological and tumor prognostic biomarker. Biochemical and Biophysical Research Communications. 745. 151221–151221. 1 indexed citations
2.
Tian, Fu‐Ju, et al.. (2024). Understanding the Anticancer Effects of Phytochemicals: From Molecular Docking to Anticarcinogenic Signaling. Journal of Nutrition. 155(2). 431–444. 2 indexed citations
3.
Zhao, Linlin, Ni Gao, Xiao-Ping Peng, et al.. (2024). TRAF4‐Mediated LAMTOR1 Ubiquitination Promotes mTORC1 Activation and Inhibits the Inflammation‐Induced Colorectal Cancer Progression. Advanced Science. 11(12). e2301164–e2301164. 11 indexed citations
4.
Ge, Xin, Peng Yuan, Zhuo Zeng, et al.. (2023). Atmosphere-inspired multilayered nanoarmor with modulable protection and delivery of Interleukin-4 for inflammatory microenvironment modulation. Biomaterials. 301. 122254–122254. 30 indexed citations
5.
Wang, Xinbo, Yueqing Chen, Xudong Wang, et al.. (2021). Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11. Cancer Research. 81(20). 5217–5229. 187 indexed citations breakdown →
6.
Li, Zhiqiang, Xuemei Gu, Meiling Lü, et al.. (2021). Luteolin promotes macrophage-mediated phagocytosis by inhibiting CD47 pyroglutamation. Translational Oncology. 14(8). 101129–101129. 16 indexed citations
7.
Zhang, Jiawen, Yunfei Chen, Xianfei Chen, et al.. (2020). Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer. Cell Death and Differentiation. 28(1). 139–155. 70 indexed citations
8.
Cai, Jinyang, Ming Sun, Bin Hu, et al.. (2019). Sorting Nexin 5 Controls Head and Neck Squamous Cell Carcinoma Progression by Modulating FBW7. Journal of Cancer. 10(13). 2942–2952. 15 indexed citations
9.
Deng, Lu, Lei Chen, Linlin Zhao, et al.. (2018). Ubiquitination of Rheb governs growth factor-induced mTORC1 activation. Cell Research. 29(2). 136–150. 96 indexed citations
10.
Wang, Xinbo, Jiali Jin, Fangning Wan, et al.. (2018). AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness. Developmental Cell. 48(3). 345–360.e7. 68 indexed citations
11.
Zhao, Linlin, Xinbo Wang, Yue Yu, et al.. (2018). OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR. Journal of Biological Chemistry. 293(13). 4883–4892. 50 indexed citations
12.
Chen, Yunfei, Jiali Jin, Yi Luan, et al.. (2017). p38 inhibition provides anti–DNA virus immunity by regulation of USP21 phosphorylation and STING activation. The Journal of Experimental Medicine. 214(4). 991–1010. 85 indexed citations
13.
Liao, Peng, Weichao Wang, & Xin Ge. (2017). In vitro Dephosphorylation Assay of c-Myc. BIO-PROTOCOL. 7(2). e2011–e2011. 1 indexed citations
14.
Sun, Yuxiang, et al.. (2017). Dyrk2 involved in regulating LPS-induced neuronal apoptosis. International Journal of Biological Macromolecules. 104(Pt A). 979–986. 10 indexed citations
15.
Yu, Su, Feng Wang, Xiao Tan, et al.. (2017). FBW7 targets KLF10 for ubiquitin-dependent degradation. Biochemical and Biophysical Research Communications. 495(2). 2092–2097. 7 indexed citations
16.
Xu, Li, Yuxiang Sun, Mengmeng Li, & Xin Ge. (2017). Dyrk2 mediated the release of proinflammatory cytokines in LPS-induced BV2 cells. International Journal of Biological Macromolecules. 109. 1115–1124. 18 indexed citations
17.
Xiao, Ning, Weijuan Pan, Dongming Liu, et al.. (2017). Smurf1 regulates lung cancer cell growth and migration through interaction with and ubiquitination of PIPKIγ. Oncogene. 36(41). 5668–5680. 34 indexed citations
18.
Jin, Jiali, Jian Liu, Zhenping Liu, et al.. (2016). The deubiquitinase USP21 maintains the stemness of mouse embryonic stem cells via stabilization of Nanog. Nature Communications. 7(1). 13594–13594. 77 indexed citations
19.
Liao, Peng, et al.. (2015). SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62. Oncogene. 35(4). 491–500. 28 indexed citations
20.
Zhang, Rong, et al.. (2007). Analgesic Peptides in Buthus martensii Karsch: A Traditional Chinese Animal Medicine. 亚洲传统医药. 2(2). 45–50. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026